Market Size of Asia-Pacific Fluoroscopy Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 1.21 Billion |
| Market Size (2029) | USD 1.56 Billion |
| CAGR (2024 - 2029) | 5.11 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
APAC Fluoroscopy Market Analysis
The Asia-Pacific Fluoroscopy Market size is estimated at USD 1.21 billion in 2024, and is expected to reach USD 1.56 billion by 2029, growing at a CAGR of 5.11% during the forecast period (2024-2029).
Fluoroscopy devices market is primarily driven by rising demand for minimally-invasive surgeries, growing geriatric population, the prevalence of chronic diseases, and increasing use of fluoroscopy in pain management.
Medical imaging has applications at various stages of inpatient management processes, such as diagnosis, staging, therapy delivery, and its follow-ups. The primary role for imaging has been diagnostics, but it is increasing slowly for interventional diagnostics and therapeutic uses that are driven by minimally-invasive procedures. Fluoroscopy presents real-time moving images for the diagnostic evaluation of soft and hard tissue conditions. It is an indispensable tool for many interventional medical procedures. The fluoroscopy market is anticipated to register significant growth, with an increasing number of minimally-invasive surgeries that are of high-precision, including the devices used, resulting in better support for both patients and surgeons. In December 2017, Hologic Inc. introduced Fluoroscan InSight FD Mini C-Arm extremities imaging system at the 2017 Radiological Society of Asia-Pacific (RSNA) annual conference in Chicago. The advancemnets in the products and new roduct launches in teh region is also boosting the market. However, the side effects associated with radiation is expected to hinder the market growth over the forecast period.
APAC Fluoroscopy Industry Segmentation
As per the scope of the report, fluoroscopy refers to an imaging technique that uses X-rays to produce real-time images of internal organs. Unlike X-ray images, which are fixed still images on film, the fluoroscopy produces live moving pictures of internal organs, which can be viewed by the naked eye on a digital monitor. This report is segmented by Device Type, Application and by Geography.
| By Device Type | ||||
| Fixed Fluoroscopes | ||||
|
| By Application | |
| Orthopedic | |
| Cardiovascular | |
| Pain Management and Trauma | |
| Neurology | |
| Gastrointestinal | |
| Urology | |
| General Surgery | |
| Other Applications |
| Geography | ||||||||
|
Asia-Pacific Fluoroscopy Market Size Summary
The Asia-Pacific fluoroscopy market is poised for significant growth, driven by the increasing demand for minimally invasive surgeries and the rising geriatric population. The market is also bolstered by the prevalence of chronic diseases and the expanding use of fluoroscopy in pain management. Fluoroscopy, which provides real-time moving images for diagnostic evaluation, is becoming increasingly important in interventional diagnostics and therapeutic applications. This shift is largely due to the growing preference for high-precision, minimally invasive procedures that enhance patient and surgeon outcomes. The introduction of advanced products, such as Hologic Inc.'s Fluoroscan InSight FD Mini C-Arm, highlights the ongoing innovation in the region, further propelling market expansion.
Despite its growth prospects, the fluoroscopy market faces challenges, particularly related to the side effects of radiation exposure, which could impede market development. However, the technology's excellent spatial and temporal resolution remains crucial for cardiovascular procedures, where it aids in navigating endovascular catheters and assessing blood flow through coronary arteries. The rising prevalence of cardiovascular diseases in the region, as evidenced by data from the Australian Bureau of Statistics, underscores the importance of fluoroscopy in managing these conditions. The market is moderately competitive, with key players like Merck KGaA, Thermo Fisher Scientific, and GE Healthcare employing strategies such as collaborations and product developments to strengthen their market positions.
Asia-Pacific Fluoroscopy Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Growing Geriatric Population and Prevalence of Chronic Diseases
-
1.2.2 Rising Demand for Minimally-invasive Surgeries
-
1.2.3 Increasing Use of Fluoroscopy in Pain Management
-
-
1.3 Market Restraints
-
1.3.1 Side Effects and Radiation Exposure
-
1.3.2 Rising Adoption of Refurbished Systems
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Device Type
-
2.1.1 Fixed Fluoroscopes
-
2.1.2 Mobile Fluoroscopes
-
2.1.2.1 Full-size Fluoroscopes
-
2.1.2.2 Mini Fluoroscopes
-
-
-
2.2 By Application
-
2.2.1 Orthopedic
-
2.2.2 Cardiovascular
-
2.2.3 Pain Management and Trauma
-
2.2.4 Neurology
-
2.2.5 Gastrointestinal
-
2.2.6 Urology
-
2.2.7 General Surgery
-
2.2.8 Other Applications
-
-
2.3 Geography
-
2.3.1 Asia-Pacific
-
2.3.1.1 China
-
2.3.1.2 Japan
-
2.3.1.3 India
-
2.3.1.4 Australia
-
2.3.1.5 South Korea
-
2.3.1.6 Rest of Asia-Pacific
-
-
-
Asia-Pacific Fluoroscopy Market Size FAQs
How big is the Asia-Pacific Fluoroscopy Market?
The Asia-Pacific Fluoroscopy Market size is expected to reach USD 1.21 billion in 2024 and grow at a CAGR of 5.11% to reach USD 1.56 billion by 2029.
What is the current Asia-Pacific Fluoroscopy Market size?
In 2024, the Asia-Pacific Fluoroscopy Market size is expected to reach USD 1.21 billion.
